EaseMyTrip Reports Rs 15 Cr Loss in Q4

May 24, 2024 17:49

EaseMyTrip reported a Rs 15.07 crore loss in the March quarter, a significant drop from the previous year's profit. The company's total income rose, but expenses also increased.

New Delhi, May 24 (PTI) Travel booking platform EaseMyTrip on Friday reported a loss of Rs 15.07 crore for the March quarter on a consolidated basis, as against a profit after tax (PAT) of Rs 31.05 crore a year ago.

For the full financial year ended March, the company reported a PAT of Rs 103.46 crore down from Rs 134.10 crore in the previous fiscal, the company said in a regulatory filing.

Its total income for the fourth quarter of FY24 rose to Rs 172.55 crore, as against Rs 120.79 crore in the year-ago period.

However, its total expenses also increased to Rs 117.48 crore in the March quarter, from Rs 76.36 crore a year ago.

The company's scrip settled at Rs 44.16, down 2.54 per cent from the previous day's close on the BSE.

Source: PTI

MORE NEWS

Corona Remedies IPO Subscribed 137 Times

Corona Remedies IPO subscribed 137.04 times on final day. QIBs subscribed 278.52 times,...

India Logistics Cost Down to 9%: Gadkari

Nitin Gadkari says India has met its target to reduce logistics cost to 9% of GDP due...

Coal Mining: Panel Urges Faster Green Clearances

Parliamentary panel urges faster environmental & forest clearances for coal mining...

DCM Shriram & Bayer Crop Science Collaboration

DCM Shriram and Bayer Crop Science partner to explore agricultural opportunities in...

Silver Price Soars to Rs 1.92 Lakh/kg on Global...

Silver prices surge Rs 11,500 to Rs 1.92 lakh/kg in Delhi amid strong global cues. Gold...

Urea Fixed Costs to Rise for Manufacturers

Govt plans to raise fixed costs for urea makers by year-end. Decision expected soon,...

Bullion Rates Today: Gold & Silver Prices

Check today''s closing bullion rates in Bengaluru. Gold (22K & 24K) prices per gram and...

Bank of India Raises Rs 2,500 Cr via Tier II Bonds

Bank of India (BoI) raised Rs 2,500 crore through Basel III-compliant Tier II bonds at...

Cipla Launches Obesity & Diabetes Drug Yurpeak

Cipla launches Yurpeak (tirzepatide), a weekly injectable for obesity and type-2...

Sebi Eases KYC for NRIs, Removes Physical Presence

Sebi relaxes re-KYC for NRIs, removing physical presence requirement for digital...

EaseMyTrip Reports Rs 15 Cr Loss in Q4

You May Like To Read

MORE NEWS